As of 2026-09-30, AstraZeneca (AZN.L) has an overall Sell technical signal, while GSK (GSK.L) reads Sell. Over the last six months AZN.L returned -18.2% versus GSK.L at -13.0% (so GSK.L has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | AZN.L | GSK.L |
|---|---|---|
| Price | 12,280.0p | 1,832.0p |
| Daily change | -1.19% | -1.29% |
| Overall signal | Sell | Sell |
| Confidence | 34% | 38% |
| 6-month return | -18.2% | -13.0% |
| RSI (14) | 50 | 43 |
| MACD | Buy | Buy |
| Trend | Downtrend | Neutral |
AstraZeneca full analysis · GSK full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.